{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:41:33Z","timestamp":1788309693525,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T00:00:00Z","timestamp":1499299200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00296-017-3770-x","type":"journal-article","created":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T00:23:31Z","timestamp":1499300611000},"page":"1513-1517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0142-6698","authenticated-orcid":false,"given":"Sulaiman M.","family":"Al-Mayouf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"AlMutiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Muzaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawiah","family":"shehata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Al-Wahadneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Abdwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safia","family":"Al-Abrawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Abu-shukair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyad","family":"El-Habahbeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Alsonbul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,6]]},"reference":[{"key":"3770_CR1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/art.11122","volume":"49","author":"E Mendez","year":"2003","unstructured":"Mendez E, Lipton R, Ramsey-Goldman R, Roettcher P, Bowyer S, Dyer A (2003) US incidence of juvenile dermatomyositis, 1995\u20131998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 49:300\u2013305","journal-title":"Arthritis Rheum"},{"key":"3770_CR2","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","volume":"28","author":"B Feldman","year":"2008","unstructured":"Feldman B, Rider L, Reed A, Pachman LM (2008) Juvenile dermatomyositis and other idiopathic inflammatory myopathies of children. Lancet 28:2201\u20132212","journal-title":"Lancet"},{"key":"3770_CR3","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.rdc.2013.06.001","volume":"39","author":"L Rider","year":"2013","unstructured":"Rider L, Katz I, Jones O (2013) Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheum Dis Clin N Am 39:877\u2013904","journal-title":"Rheum Dis Clin N Am"},{"key":"3770_CR4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.berh.2004.01.003","volume":"18","author":"L Wedderburn","year":"2004","unstructured":"Wedderburn L, Li C (2004) Paediatric idiopathic inflammatory muscle disease. Best Pract Res Clin Rheumatol 18:345\u2013358","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3770_CR5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/1756-185X.12107","volume":"16","author":"P Gowdie","year":"2013","unstructured":"Gowdie P, Allen R, Kornberg A, Akikusa J (2013) Clinical features and disease course of patients with juvenile dermatomyositis. Int J Rheum Dis 16:561\u2013567","journal-title":"Int J Rheum Dis"},{"key":"3770_CR6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/08916930600622819","volume":"39","author":"T Constantin","year":"2006","unstructured":"Constantin T, Ponyi A, Orban I, Molnar K, Derfalvi B, Dicso F (2006) National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary\u2014clinical characteristics and disease course of 44 patients with juvenile dermatomyositis. Autoimmunity 39:223\u2013232","journal-title":"Autoimmunity"},{"key":"3770_CR7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MD.0b013e31827f264d","volume":"92","author":"M Shah","year":"2013","unstructured":"Shah M, Mamyrova G, Targoff I, Huber A, Malley J, Rice M et al (2013) The clinical phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 92:25\u201341","journal-title":"Medicine (Baltimore)"},{"key":"3770_CR8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/BOR.0000000000000103","volume":"26","author":"F Ernste","year":"2014","unstructured":"Ernste F, Reed A (2014) Recent advances in juvenile idiopathic inflammatory myopathies. Curr Opin Rheumatol 26:671\u2013678","journal-title":"Curr Opin Rheumatol"},{"key":"3770_CR9","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s10067-014-2747-3","volume":"33","author":"S Singh","year":"2016","unstructured":"Singh S, Suri D, Aulakh R, Gupta A, Rawat A, Kumar R (2016) Mortality in children with juvenile dermatomyositis: two decades of experience from a single tertiary care in North India. Clin Rheumatol 33:1675\u20131679","journal-title":"Clin Rheumatol"},{"key":"3770_CR10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00296-016-3467-6","volume":"36","author":"I Saini","year":"2016","unstructured":"Saini I, Kalaivani M, Kabra S (2016) Calcinosis in juvenile dermatomyositis: frequency, risk factors and outcome. Rheumatol Int 36:961\u2013965","journal-title":"Rheumatol Int"},{"key":"3770_CR11","first-page":"117","volume":"29","author":"D Guseinova","year":"2011","unstructured":"Guseinova D, Consolaro A, Trail L, Ferrari C, Pistorio A, Ruperto N et al (2011) European and Latin American patients with juvenile dermatomyositis. Clin Exp Rheumatol 29:117\u2013124","journal-title":"Clin Exp Rheumatol"},{"key":"3770_CR12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1529-0131(200003)43:3<541::AID-ANR9>3.0.CO;2-T","volume":"43","author":"A Huber","year":"2000","unstructured":"Huber A, Lang B, LeBlanc C, Birdi N, Bolaria R, Mallseon P et al (2000) Medium-and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 43:541\u2013549","journal-title":"Arthritis Rheum"},{"key":"3770_CR13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/s10165-012-0647-4","volume":"23","author":"T Kishi","year":"2013","unstructured":"Kishi T, Miyamae T, Hara R, Nakajima S, Imagawa T, Mori M et al (2013) Clinical analysis of 50 children with dermatomyositis. Mod Rheumatol 23:311\u2013317","journal-title":"Mod Rheumatol"},{"key":"3770_CR14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pedneo.2014.02.006","volume":"56","author":"C Sun","year":"2015","unstructured":"Sun C, Lee J, Yang Y, Yu H, Wang L, Lin Y et al (2015) Juvenile dermatomyositis: a 20-year retrospective analysis of treatment and clinical outcomes. Pediatr Neonatol 56:31\u201339","journal-title":"Pediatr Neonatol"},{"key":"3770_CR15","first-page":"115","volume":"17","author":"R Shehata","year":"1999","unstructured":"Shehata R, Al-Mayouf S, Al-Dalaan A, Al-Mazaid A, Al-Balaa S, Bahabri S (1999) Juvenile dermatomyositis: clinical profile and disease course in 25 patients. Clin Exp Rheumatol 17:115\u2013118","journal-title":"Clin Exp Rheumatol"},{"key":"3770_CR16","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/annrheumdis-2012-201483","volume":"72","author":"D Lazarevic","year":"2013","unstructured":"Lazarevic D, Pistorio A, Palmisani E, Miettunen P, Ravelli A, Pilkington C et al (2013) The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Ann Rheum Dis 72:686\u2013693","journal-title":"Ann Rheum Dis"},{"key":"3770_CR17","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/rheumatology\/kel099","volume":"45","author":"L McCann","year":"2006","unstructured":"McCann L, Junggins A, Maillard S, Wedderburn L, Davidson J, Murray K et al (2006) The juvenile dermatomyositis national registry and repository (UK and Ireland)-clinical characteristics of children recruited with the first 5 yr. Rheumatology (Oxford) 45:1255\u20131260","journal-title":"Rheumatology (Oxford)"},{"key":"3770_CR18","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1002\/art.23960","volume":"58","author":"E Stringer","year":"2008","unstructured":"Stringer E, Singh-Grewal D, Feldman B (2008) Predicting the course of juvenile dermatomyositis. Arthritis Rheum 58:3585\u20133592","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3770_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1546-0096-10-34","volume":"10","author":"A Patwardhan","year":"2012","unstructured":"Patwardhan A, Rennebohm R, Dvorchik I, Spencer C (2012) Is juvenile dermatomyositis a different disease in children up to three years of age at onset than in children above three years at onset? A retrospective review of 23\u00a0years of a single center\u2019s experience. Pediatr Rheumatol Online J 10(1):34. doi:\n                        10.1186\/1546-0096-10-34","journal-title":"Pediatr Rheumatol Online J"},{"key":"3770_CR20","first-page":"50","volume":"23","author":"A Ponyi","year":"2005","unstructured":"Ponyi A, Constantin T, Balogh Z, Szalai Z, Borgulya G, Molnar K et al (2005) Disease course, frequency of relapses and survival of 73 patients with juvenile or adult dermatomyositis. Clin Exp Rehuamtol 23:50\u201356","journal-title":"Clin Exp Rehuamtol"},{"key":"3770_CR21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s100670050032","volume":"19","author":"SM Al-Mayouf","year":"2000","unstructured":"Al-Mayouf SM, Al-Mazyed A, Bahabri S (2000) Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolone and methotrexate. Clin Rheumatol 19:138\u2013141","journal-title":"Clin Rheumatol"},{"key":"3770_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209247","author":"F Enders","year":"2016","unstructured":"Enders F, Bader-Meunier B, Baildam E, Constantin T, Dolezalova P, Feldman B et al (2016) Consensus-based recommendations for the management of juvenile dermatomyositis. Ann Rheum Dis. doi:\n                        10.1136\/annrheumdis-2016-209247","journal-title":"Ann Rheum Dis"},{"key":"3770_CR23","first-page":"2498","volume":"27","author":"SM Al-Mayouf","year":"2000","unstructured":"Al-Mayouf SM, Laxer R, Schneider R, Silverman E, Feldman B (2000) Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety. J Rheumatol 27:2498\u20132503","journal-title":"J Rheumatol"},{"key":"3770_CR24","first-page":"135","volume":"28","author":"A Marco Puche","year":"2010","unstructured":"Marco Puche A, Calvo Penades I, Lopez Montesinos B (2010) Effectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis. Clin Exp Rheumatol 28:135\u2013140","journal-title":"Clin Exp Rheumatol"},{"key":"3770_CR25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/rheumatology\/kep302","volume":"48","author":"H Sanner","year":"2009","unstructured":"Sanner H, Gran J, Sjaastad I, Flato B (2009) Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8\u00a0years symptom onset. Rheumatology (Oxford) 48:154\u2013157","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-017-3770-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3770-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3770-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T06:20:43Z","timestamp":1503555643000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-017-3770-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,6]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["3770"],"URL":"https:\/\/doi.org\/10.1007\/s00296-017-3770-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,6]]}}}